Ciencias de la Salud
Domaine de connaissance
AstraZeneca (United Kingdom)
Cambridge, Reino UnidoPublications en collaboration avec des chercheurs de AstraZeneca (United Kingdom) (14)
2024
2021
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
-
In Vitro Models for Studying Respiratory Host–Pathogen Interactions
Advanced Biology, Vol. 5, Núm. 6
2018
-
Comparison of plasma ctDNA and tissue/cytology-based techniques for the detection of EGFR mutation status in advanced NSCLC: Spanish data subset from ASSESS
Clinical and Translational Oncology, Vol. 20, Núm. 10, pp. 1261-1267
2017
-
Lesinurad, a Selective Uric Acid Reabsorption Inhibitor, in Combination With Febuxostat in Patients With Tophaceous Gout: Findings of a Phase III Clinical Trial
Arthritis and Rheumatology, Vol. 69, Núm. 9, pp. 1903-1913
2016
-
Computational Lexical Analysis of the Language Commonly Used to Describe Gout
Arthritis Care and Research, Vol. 68, Núm. 6, pp. 763-768
2013
-
Occupational disability in bipolar disorder: Analysis of predictors of being on severe disablement benefit (PREBIS study data)
Acta Psychiatrica Scandinavica, Vol. 127, Núm. 5, pp. 403-411
2012
-
Predictors of recurrence in bipolar disorders in Spain (PREBIS study data)
Journal of Affective Disorders, Vol. 141, Núm. 2-3, pp. 406-414
-
Validación de la versión en castellano de la Escala del Bienestar Subjetivo con Neurolépticos (SWN-K) en pacientes con esquizofrenia
Medicina Clinica, Vol. 138, Núm. 4, pp. 151-154
2010
-
Bases neurobiológicas del efecto antidepresivo de la quetiapina en el trastorno bipolar
Actas Espanolas de Psiquiatria, Vol. 38, Núm. 1, pp. 22-32
2009
-
Gut microbiome modulates the toxicity of hydrazine: A metabonomic study
Molecular BioSystems, Vol. 5, Núm. 4, pp. 351-355
2008
-
Validity and reliability of the Spanish versions of the Bech-Rafaelsen's mania and melancholia scales for bipolar disorders
Acta Psychiatrica Scandinavica, Vol. 117, Núm. 3, pp. 207-215
2007
-
Sensitivity to change, discriminative performance, and cutoff criteria to define remission for embedded short scales of the Hamilton depression rating scale (HAMD)
Journal of Affective Disorders, Vol. 102, Núm. 1-3, pp. 93-99
-
The sufficiency of the HAM-D6 as an outcome instrument in the acute therapy of antidepressants in the outpatient setting
International Journal of Psychiatry in Clinical Practice, Vol. 11, Núm. 2, pp. 146-150